Delivery Order SPE2DB22D3301-SPE2DB25FZ1RM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $18,314.10 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 10 gram/100 mL vials on August 27, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal government. The contract will be performed at...
- The Defense Logistics Agency awarded a $23,602.80 delivery order to AmerisourceBergen Drug Corp for GAMUNEX-C 20 gram/200 mL vials on September 4, 2025, with completion targeted for September 25, 2025. This firm fixed-price delivery order represents a non-competitive, non-set-aside procurement issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be...
- The Defense Logistics Agency awarded a $13,963.20 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials with a completion date of September 23, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order is structured as a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $27,926.40 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. This competitively awarded, firm fixed-price contract, with no set-aside designation, is scheduled for completion by October 20, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $33,528.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Gamunex-C 10 gram/100 mL vials. The contract is scheduled for completion by October 17, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $18,882.24 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 20 gram/200 mL vials on September 12, 2025. This firm fixed price, competitively awarded delivery order is scheduled for completion by October 3, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's proven capability to compete successfully in...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $140,028.96 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Gamunex-C 40 gram/400 mL vials. This firm fixed-price delivery order, with an ultimate completion date of October 6, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,731.28 to AmerisourceBergen Drug Corp for the supply of Gamunex-C 2.5 grams per 25 milliliter vials. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement supporting the DLA's medical supply chain operations. The order is scheduled for completion by October 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $46,544 firm fixed-price delivery order on August 12, 2025, for the supply of GAMUNEX-C 40 gram/400 milliliter vials. The contract is unclassified as a set-aside and has an ultimate completion date of September 3, 2025. AmerisourceBergen will perform this delivery order from its corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Gamunex-C 5 gram/50 milliliter vials valued at $3,644.04 with a completion date of October 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1RMDelivery Order
The Defense Logistics Agency awarded a $28,323.36 delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Gamunex-C 20 gram/200 mL vials. This is a firm fixed price, non-set-aside contract with a completion date of October 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's medical supply chain. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a prime vendor for pharmaceutical and medical supplies, AmerisourceBergen supplies a comprehensive range of products including specialty medications, vaccines, and medical devices to support military healthcare programs globally. The company's federal contract portfolio demonstrates consistent capability to fulfill competitively awarded procurement requirements across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.3k | 9/26/25 |